For the tenth time the cancer experts gathered to share knowledge and ideas at Oslo Cancer Cluster Innovation Park. Cancer Crosslinks 2018 presented a diverse program covering themes from immuno-oncology to cachexia, to big data.
Cancer research is changing rapidly. Immunotherapy  and precision medicine  has revolutionized cancer treatment. This year’s Cancer Crosslinks took a closer look at developments over the last decade, and highlighted “Precision Treatment: Exploiting Recent Advances – Fast and Furious?”.
Weber Gazed into the Crystal Ball
The leading immunotherapy expert professor Jeffrey S. Weber visited Cancer Crosslinks for a second time. Weber has worked with immunotherapy for 30 years. He provided an overview on recent advances. He shared new data showing that the combination of a certain vaccine and a type of immunotherapy called Checkpoint inhibitors, are especially effective against cancer. He also gazed into the crystal ball and made predictions on the future of cancer treatment. Weber is optimistic and thinks there are several promising combinations of precision treatments on the horizon. He believes we can hope for a survival rate of 70-80 percent for people with certain cancers.
A Fiber Diet is Recommendable
Professor Laure Bindels from Belgium explored the theme of Microbiome , Cancer and Cachexia . Diet can be an important tool to fight cancer and cancer symptoms. Her research on mice indicates that changing to a fiber-rich diet can prevent undernourishment and increase the survival rate for cancer patients.
Hege Russnes and Anne Hansen Ree introduced us to the MetAction project where they conduct extended personal diagnostic testing to give cancer patients better and more effective treatment.
From the USA, we were introduced to precision treatment of gynecological cancer from Douglas A. Levine. He was followed by Professor Andreas Engert, who raised the hot topic of establishing joint European guidelines for treatment across Europe for hematological cancer.
A Big Maybe to Big Data
The last speakers of the day where Assistant Professor Marcela Maus from Harvard Medical School, and Elisabeth Wik and Marc Vaudel from the University of Bergen. Professor Maus explained the use of CAR T- cells  in cancer treatment. CAR-T Cells are T-cells with modified receptors to make them more effective against certain diseases, in this case cancer.
Elisabeth Wik and Marc Vaudel, with backgrounds from cancer research and computer science, discussed the use of big data in cancer research and treatment. Will big data revolutionize cancer treatment? The answer is maybe. We don’t know yet, it has potential. We need to continue exploration, research, and collaboration to find out.
Download the Presentations
For those of you who missed the event or would like to revisit:
You can download presentations from the meeting here:
Opening and Welcome  with Jutta Heix from Oslo Cancer Cluster and Anne Kjersti Fahlvik, Executive Director Innovation, The Norwegian Research Council.
Jeffrey S. Weber . Opening Keynote: Cancer Immunotherapy – The Journey So Far and Where We Are Heading.
Jeffrey S. Weber, Professor, Deputy Director and Co-Director, Melanoma Program, Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, USA.
Laure Bindels . International Keynote: The Microbiome, Cancer and Cachexia.
Laure Bindels, Louvain Drug Research Institute, Université catholique de Louvain, Belgium.
Hege G. Russnes and Anne Hansen Ree  : From Feasibility to Utility in Precision Medicine – Experiences from the first Norwegian Study of NGS-Based Therapy Decisions in Advanced Cancer.
Hege G. Russnes, Senior Consultant and Researcher, Oslo University Hospital, Norwegian Radium Hospital, Norway
Anne Hansen Ree, Professor, Akershus University Hospital, University of Oslo, Norway
Douglas A. Levine . International Keynote: Precision Medicine for Gynecologic Cancers – Opportunities and Obstacles.
Douglas A. Levine, Professor, Director of Gynecologic Oncology, Laura and Isaac Perlmutter Cancer Center & Head, Gynecology Research Laboratory, NYU Langone Medical Center, New York, USA.
Andreas Engert . International Keynote: Roadmap for European Hematology Research and Hodgkin Lymphoma: (Immuno)therapy, Late Effects and the Way Forward.
Andreas Engert, Professor for Internal Medicine, Hematology and Oncology, University Hospital of Cologne, Germany.
Marcela V. Maus . International Keynote: The Next Generation of Engineered T-cells for Immunotherapy of Hematological and Solid Tumors.
Marcela V. Maus, Assistant Professor, Harvard Medical School & Director of Cellular Immunotherapy, Cancer Center, Massachusetts General Hospital, Boston, USA.
Marc Vaudel and Elisabeth Wik : Making Sense of Big Data for Oncology Patients – Vision and Reality
Marc Vaudel, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital and KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Norway
Elisabeth Wik, Centre for Cancer Biomarkers, University of Bergen and Department of Pathology, Haukeland University Hospital, Norway